121 related articles for article (PubMed ID: 38723899)
1. High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia.
Zuliani G; Brombo G; Polastri M; Romagnoli T; Mola G; Riccetti R; Seripa D; Trentini A; Cervellati C
Neurochem Int; 2024 Jul; 177():105763. PubMed ID: 38723899
[TBL] [Abstract][Full Text] [Related]
2. Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment.
Zuliani G; Trentini A; Brombo G; Rosta V; Guasti P; Romagnoli T; Polastri M; Marabini L; Pedrini D; Pistolesi C; Pacifico S; Guerrini R; Seripa D; Cervellati C
J Neurochem; 2021 Nov; 159(3):629-637. PubMed ID: 34534363
[TBL] [Abstract][Full Text] [Related]
3. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.
Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M
J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318
[TBL] [Abstract][Full Text] [Related]
5. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
[TBL] [Abstract][Full Text] [Related]
6. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
7. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
8. Conversion pattern and predictive factor of mild cognitive impairment in elderly Koreans.
Shim SM; Song J; Kim JH; Jeon JP
Arch Gerontol Geriatr; 2016; 64():146-50. PubMed ID: 26896864
[TBL] [Abstract][Full Text] [Related]
9. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
11. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
[TBL] [Abstract][Full Text] [Related]
13. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
14. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
Putcha D; Tremont G
J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
[TBL] [Abstract][Full Text] [Related]
15. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
17. Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.
Oltra-Cucarella J; Ferrer-Cascales R; Alegret M; Gasparini R; Díaz-Ortiz LM; Ríos R; Martínez-Nogueras ÁL; Onandia I; Pérez-Vicente JA; Cabello-Rodríguez L; Sánchez-SanSegundo M
Psychol Aging; 2018 Nov; 33(7):1007-1021. PubMed ID: 30284855
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.
Wu L; Arvai S; Wang SJ; Liu AJ; Xu B
Front Mol Neurosci; 2023; 16():1288930. PubMed ID: 38260807
[TBL] [Abstract][Full Text] [Related]
19. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
[TBL] [Abstract][Full Text] [Related]
20. Data-driven classification of cognitively normal and mild cognitive impairment subtypes predicts progression in the NACC dataset.
Edmonds EC; Thomas KR; Rapcsak SZ; Lindemer SL; Delano-Wood L; Salmon DP; Bondi MW
Alzheimers Dement; 2024 May; 20(5):3442-3454. PubMed ID: 38574399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
